Sickle Cell Anemia Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC571

Introduction

Sickle cell disease is an inherited group of syndrome in which RBCs twist to sickle shape. A cluster of syndromes causes red blood cells (RBCs) to become distorted and break down. Some of the common symptoms of sickle cell disease are pain, infection and fatigue. Popular treatments for this disease include rarely a bone-marrow transplant, blood transfusions and medication.

Market Dynamics

Growing geriatric population in major economies and rising healthcare spending and demand for drug therapy in combination with blood transfusion and surgeries are driving the market growth. In addition, overall cost of sickle cell disease diagnosis is reduced, which in turn, is majorly influencing the market growth. However, adverse effects from sickle cell anemia such as intravenous catheter associated infections, liver in-toxicity and low hemoglobin are impeding the growth of this market. Government emphasis on spreading awareness about sickle cell anemia cure combined with augmentation of FDA approved drug accessibility are propelling the market expansion over the forecast period.

 Market Classification

The sickle cell anemia drug market is segmented on the basis of mode of delivery, end-user and geography. Based on mode of delivery, the market is classified into oral and injection. Based on type, the market is classified into hospital, clinic and others. Based on geography, market is divided into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Report Coverage

Market

Sickle Cell Anemia Drug Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Mode of Delivery, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

The market players in the sickle cell anemia drug market include Alnylam Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Baxter International Inc., Emmaus Life Sciences, Inc., Novartis AG, AstraZeneca Plc., Sangamo Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics Inc., Bristol-Myers Squibb Company, Acceleron Pharma, Inc. and Arena Pharmaceuticals, Inc. among others.

Market Segmentation

Market By Mode of Delivery

·         Oral

·         Injection

Market By End-Users

·         Hospital

·         Clinic

·         Others

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Healthcare Consulting Services Market By Type of Service (IT Consulting, Digital consulting, Financial Consulting, Operation Consulting, Strategy Consulting, HR & Talent Consulting), By End User (Life Science Companies, Hospitals, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta

Healthcare Analytics Market By Application (Financial, Clinical, Population Health Analytics, Operational & administrative), By Type (Descriptive, Predictive, Prescriptive, Cognitive), By Deployment Mode (On-premise, On-demand), By End-User (Payer, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare analytics market size is expected to hit around US$ 52.2 Bn by 2026 and will grow at a CAGR of around 23.4% over the forecast period 2019 to 2026. Healthcare analytics are the solutions that involve all the healthcare analysis activities by using data from the key areas of the healthcare: pharmaceutical and R&D data, patient behaviors data, clinical data, and claims & cost data. H

Electronic Health Record Market By Product (Web-based, Client Server-based), By Type (Ambulatory, Acute, Post-Acute), By End Use (Ambulatory Care, Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global electronic health record market size is expected to reach over US$ 30 Bn by 2026 and is anticipated to grow at a CAGR over 5.5% in terms of revenue during the forecasting period from 2019 to 2026. EMRs refer to both individual patient documents and usually to systems that retain patient documents and serve as data entry interfaces and test ordering, other processes and p

Medical Electronics Market By Application (Imaging, Therapeutics, Patient Monitoring, Homecare/Handheld Products), By End Use (Hospital, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global medical electronics market value is expected to surpass US$ 122 Bn by 2026 and is anticipated to grow at a CAGR of around 6% in terms of revenue during the forecast period from 2019 to 2026. Medical electronics refer to a certain category of electronic instruments and equipment specifically used for medical application such as diagnosis, treatment, study, control of anes

Cart Summary